US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Adicet Bio, Inc. - Common Stock (NQ:ACET)

6.500 -0.140 (-2.11%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Adicet Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
ACET Stock Earnings: Adicet Bio Beats EPS for Q1 2024 ↗
ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness ↗
Although speculation can be bad for your blood pressure, these compelling penny stocks have some strong endorsements. 
Via InvestorPlace
News headline image
ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023 ↗
ACET stock results show that Adicet Bio met analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
3 High-Risk Stocks That Could Pay Off in the Millions ↗
With the S&P 500 at record highs, betting on these high-risk stocks that could pay off is a tantalizing prospect at this time. 
Via InvestorPlace
Topics Stocks
News headline image
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
7 Top-Tier Penny Stocks for a Smart Bet ↗
Unlock value in penny stocks amid bullish S&P 500 trends and shifting monetary policies, focusing on businesses with solid drivers 
Via InvestorPlace
Topics Stocks
News headline image
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory ↗
Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money. 
Via InvestorPlace
News headline image
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio, Inc. Announces Pricing of Public Offering
From Adicet Bio, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Adicet Bio, Inc. Announces Proposed Public Offering
From Adicet Bio, Inc.
Via Business Wire
News headline image
IN8bio's Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data ↗
IN8bio (NASDAQ: INAB) is a biotechnology company that specializes in developing novel therapies based on gamma-delta T cells. Its innovative technology focuses on harnessing the potential of these... 
Via Benzinga
News headline image
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention. 
Via Benzinga
News headline image
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.< 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >